NCT01678508View on ClinicalTrials.gov

Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia

CompletedOBSERVATIONAL
Enrollment

1,020

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

July 31, 2011

Study Completion Date

February 29, 2012

Conditions
Acute Lymphoblastic Leukemia
Trial Locations (1)

2100

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT01678508 - Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter